Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.
OBJECTIVE: EFEMP1, the epidermal growth factor-containing fibulin-like extracellular matrix protein 1, functions as an oncogene or a tumor suppressor depending on the cancer types. In this study, we aim to determine whether EFEMP1 affects the tumorigenesis and progression of endometrial carcinoma. M...
Main Authors: | Tingting Yang, Haifeng Qiu, Wei Bao, Bilan Li, Cong Lu, Guiqiang Du, Xin Luo, Lihua Wang, Xiaoping Wan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3696089?pdf=render |
Similar Items
-
Overexpression of EFEMP1 correlates with tumor progression and poor prognosis in human ovarian carcinoma.
by: Jie Chen, et al.
Published: (2013-01-01) -
Utility of EFEMP1 in the Prediction of Oncologic Outcomes of Urothelial Carcinoma
by: Tzu-Ju Chen, et al.
Published: (2021-06-01) -
The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma
by: Julia Paczkowska, et al.
Published: (2020-10-01) -
Epigenetic changes as prognostic predictors in endometrial carcinomas
by: Sanja A. Farkas, et al.
Published: (2017-01-01) -
Correction: OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
Published: (2008-01-01)